JP2006151999A5 - - Google Patents

Download PDF

Info

Publication number
JP2006151999A5
JP2006151999A5 JP2006055107A JP2006055107A JP2006151999A5 JP 2006151999 A5 JP2006151999 A5 JP 2006151999A5 JP 2006055107 A JP2006055107 A JP 2006055107A JP 2006055107 A JP2006055107 A JP 2006055107A JP 2006151999 A5 JP2006151999 A5 JP 2006151999A5
Authority
JP
Japan
Prior art keywords
crystal
tautomer
solvate
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006055107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006151999A (ja
JP4504323B2 (ja
Filing date
Publication date
Priority claimed from GBGB9713730.1A external-priority patent/GB9713730D0/en
Application filed filed Critical
Publication of JP2006151999A publication Critical patent/JP2006151999A/ja
Publication of JP2006151999A5 publication Critical patent/JP2006151999A5/ja
Application granted granted Critical
Publication of JP4504323B2 publication Critical patent/JP4504323B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006055107A 1997-06-30 2006-03-01 結晶性マクロライドおよびその調製方法 Expired - Lifetime JP4504323B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP50628799A Division JP3880634B2 (ja) 1997-06-30 1998-06-26 結晶性マクロライドおよびその調製方法

Publications (3)

Publication Number Publication Date
JP2006151999A JP2006151999A (ja) 2006-06-15
JP2006151999A5 true JP2006151999A5 (enExample) 2006-12-07
JP4504323B2 JP4504323B2 (ja) 2010-07-14

Family

ID=10815103

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50628799A Expired - Lifetime JP3880634B2 (ja) 1997-06-30 1998-06-26 結晶性マクロライドおよびその調製方法
JP2006055107A Expired - Lifetime JP4504323B2 (ja) 1997-06-30 2006-03-01 結晶性マクロライドおよびその調製方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP50628799A Expired - Lifetime JP3880634B2 (ja) 1997-06-30 1998-06-26 結晶性マクロライドおよびその調製方法

Country Status (31)

Country Link
US (1) US6423722B1 (enExample)
EP (1) EP0994880B1 (enExample)
JP (2) JP3880634B2 (enExample)
KR (1) KR100399765B1 (enExample)
CN (1) CN1139595C (enExample)
AR (1) AR017754A1 (enExample)
AT (1) ATE287410T1 (enExample)
AU (1) AU739211B2 (enExample)
BR (1) BR9810956A (enExample)
CA (1) CA2290412C (enExample)
CO (1) CO4940463A1 (enExample)
CZ (1) CZ297244B6 (enExample)
DE (1) DE69828692T2 (enExample)
DK (1) DK0994880T3 (enExample)
ES (1) ES2236922T3 (enExample)
GB (1) GB9713730D0 (enExample)
HU (1) HU227755B1 (enExample)
ID (1) ID24897A (enExample)
IL (1) IL132761A0 (enExample)
MY (1) MY118718A (enExample)
NO (1) NO312765B1 (enExample)
NZ (1) NZ500994A (enExample)
PE (1) PE97699A1 (enExample)
PL (1) PL192761B1 (enExample)
PT (1) PT994880E (enExample)
RU (1) RU2219181C2 (enExample)
SK (1) SK285665B6 (enExample)
TR (1) TR199903189T2 (enExample)
TW (1) TW552264B (enExample)
WO (1) WO1999001458A1 (enExample)
ZA (1) ZA985655B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
US7875630B2 (en) * 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use
AU2005230401B2 (en) * 2004-04-08 2008-11-27 Meda Pharma S.A.R.L. Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
TW200628483A (en) 2004-12-01 2006-08-16 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Processes for producing crystalline macrolides
EP1960406A2 (en) * 2006-11-06 2008-08-27 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
EP2099298A4 (en) * 2006-12-07 2010-01-06 Helsinn Healthcare Sa CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
EP2451496B1 (en) 2009-07-10 2015-07-22 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
WO2011008393A2 (en) 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8669360B2 (en) * 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
SG10202112135VA (en) 2013-03-15 2021-12-30 Biosensors International Group Ltd Purification of rapamycin derivatives
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
WO2018202733A1 (en) * 2017-05-01 2018-11-08 Meda Pharma Gmbh & Co. Kg Process to convert crude ascomycin into purified pimecrolimus
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
WO2024209038A1 (en) 2023-04-06 2024-10-10 Premark Pharma Gmbh Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
GB2084580B (en) 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
JPH089630B2 (ja) 1989-07-10 1996-01-31 ヘマ・ソシエダード・アノニマ 有機化合物の、または関連する改善
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
IE910847A1 (en) * 1990-03-13 1991-09-25 Fisons Plc Immunosuppressive macrocyclic compounds
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
ES2100291T3 (es) 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
JP3808500B2 (ja) * 1994-02-22 2006-08-09 キューレータズ オブ ディ ユニバーシティ オブ ミズーリ 分離剤としての大環状抗生物質
WO1997008182A1 (en) * 1995-08-24 1997-03-06 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2006151999A5 (enExample)
CN103261187B (zh) 制备四唑取代的邻氨基苯甲酰胺衍生物的方法以及这些衍生物的晶体多形体
JP2020518662A (ja) 化合物の結晶多形、その製造方法及び用途
CA2572147A1 (en) Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
CN103951634B (zh) 一种依帕司他结晶盐水合物和羟基哌啶共晶物及其制备方法和应用
JP2020517611A5 (enExample)
JP2014500357A5 (enExample)
JP2013049690A5 (enExample)
RU2015143643A (ru) Соль омекамтива мекарбила и способ ее получения
JP2016537346A5 (enExample)
RU2014123567A (ru) Кристаллическая 7{(3s, 4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил}-6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1, 4-дигидрохинолин-3-карбоновая кислота
JP2015508092A5 (enExample)
JP2014528948A5 (enExample)
RS61986B1 (sr) Hemisulfat so 5,10-metilen-(6)-tetrahidrofolne kiseline
ES2879294T3 (es) Formas polimórficas de Belinostat y procesos para la preparación de las mismas
CN106687470A (zh) 结晶形式的索非布韦及其制备方法
JP2016510768A5 (enExample)
RU2016106125A (ru) Соли дасатиниба в кристаллической форме
JP2004513106A (ja) 塩酸ベンラファキシンの結晶形
KR102878525B1 (ko) 피리미디닐아미노-피라졸 화합물의 다형체와 고체 형태, 그리고 생산 방법
JP2009040767A5 (enExample)
CN102807575B (zh) 3-芳基-5-噻吩基-5H-噻唑并[3,2-a]嘧啶类衍生物及其应用
CN103965116A (zh) 半5-氟胞嘧啶盐、其制备方法及应用
JP2013541589A5 (enExample)
JP2019529553A5 (enExample)